# Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation

Study · id `cardio:ct-nct01162902` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01162902](<https://clinicaltrials.gov/study/NCT01162902>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01162902

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT01162902. Randomized; single masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2015-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT01162902, source copy `cardio:ctgov-nct01162902-2013-12-17`, retrieved 2026-10-31)
- Start date: 2013-09 (registry gives no type) (ClinicalTrials.gov record NCT01162902, source copy `cardio:ctgov-nct01162902-2013-12-17`, retrieved 2026-10-31)
- Primary completion: 2015-01 (anticipated) (ClinicalTrials.gov record NCT01162902, source copy `cardio:ctgov-nct01162902-2013-12-17`, retrieved 2026-10-31)
- Completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01162902, source copy `cardio:ctgov-nct01162902-2013-12-17`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT01162902, source copy `cardio:ctgov-nct01162902-2013-12-17`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01162902-2013-12-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation
- Condition: Stable Angina
- Intervention (Drug): Diltiazem treated group
- Intervention (Drug): Bisoprolol treated group
- Intervention (Drug): Candesartan treated group
- Lead sponsor: Seoul National University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)

## Provenance

Content hash: 6fb05d9c45ff0cccba523e60a802cf3ce7d3f72f88f2d6b573d7f68c1181349b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
